TickerFacts.

Vyome Holdings, Inc (HIND): Revenue

Annual figures by period end, from SEC filings.

$319.7K
Year ended 2025-12-31
$129.7K
Trailing 12 months to 2026-06-30
-69.5%
3-year compound annual growth
-51.0%
5-year compound annual growth
-22.4%
10-year compound annual growth
$13.60M2014-12-31: $3.54M2015-12-31: $4.04M2016-12-31: $3.39M2017-12-31: $9.91M2018-12-31: $9.10M2019-12-31: $3.28M2020-12-31: $11.30M2021-12-31: $13.60M2022-12-31: $11.24M2023-12-31: $8.68M2024-12-31: $256.9K2025-12-31: $319.7K$319.7K
2014-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$319.7K+24.4%2026-03-18, From 2025-01-01
2024-12-31$256.9K-97.0%2026-03-18, From 2024-01-01
2023-12-31$8.68M-22.8%2025-04-04, From 2023-01-01
2022-12-31$11.24M-17.4%2024-04-01, From 2022-01-01
2021-12-31$13.60M+20.4%2023-04-17, From 2021-01-01
2020-12-31$11.30M+244.4%2022-04-08, From 2020-01-01
2019-12-31$3.28M-63.9%2021-03-12, From 2019-01-01
2018-12-31$9.10M-8.2%2019-02-22, From 2018-01-01
2017-12-31$9.91M+192.2%2019-02-22, From 2017-01-01
2016-12-31$3.39M-16.0%2018-03-05, From 2016-01-01
2015-12-31$4.04M+14.1%2018-03-05, From 2015-01-01
2014-12-31$3.54Mn/a2017-02-23, From 2014-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Vyome Holdings, Inc (HIND)2025-12-31$319.7K+24.4%
Allarity Therapeutics, Inc. (ALLR)2025-12-31$320.0Kn/a
Provectus Biopharmaceuticals, Inc. (PVCT)2025-12-31$336.1K-45.5%
Abvc Biopharma, Inc. (ABVC)2025-12-31$296.0K-41.9%
Can-Fite BioPharma Ltd. (CANF)2025-12-31$405.0K-39.9%
Medicinova Inc (MNOV)2025-12-31$409.7Kn/a
Scienture Holdings, Inc. (SCNX)2025-12-31$431.6K+215.9%
Regen BioPharma Inc (RGBP)2025-09-30$236.6K0.0%
Mereo BioPharma Group plc (MREO)2025-12-31$500.0Kn/a

Compare HIND, ALLR, PVCT, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗